Investigational Device
Exemptions Reports and Records - 21 CFR 812
No
material or nonsubstantive change to a currently approved
collection
No
Regular
05/19/2021
Requested
Previously Approved
11/30/2022
11/30/2022
16,648
16,648
45,782
45,782
0
0
The Food and Drug Administration (FDA)
is requesting approval from the Office of Management and Budget
(OMB) for information collection requirements contained in 21 CFR,
Part 812. The IDE regulation permits a device to be shipped in
interstate commerce for clinical investigation to determine its
medical safety and effectiveness. Although the IDE regulations
exempts the device from certain requirements of the Act, it
requires safeguards for humans who are subjects of investigations;
maintenance of sound ethical standards; and procedures to assure
development of reliable scientific data.
The estimated annual reporting
burden for this extension has decreased to 38,080 hours (previously
38,505 hours) as the result of a decrease in the average number of
applications and supplements submitted. For the same reason, the
recordkeeping burden has decreased to 7,696 hours (previously
7,800). The previous approved total burden hours of 46,311, have
therefore decreased by 529 to 45,782 total burden hours.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.